ASP 0892

Drug Profile

ASP 0892

Alternative Names: ARA h1,2,3-Lamp-vax peanut vaccine; ARA-LAMP-Vax™; ASP0892; Peanut allergy vaccine - Immunomic

Latest Information Update: 22 Dec 2016

Price : *
* Final gross price and currency may vary according to local VAT and billing address.

At a glance

  • Originator Immunomic Therapeutics
  • Developer Astellas Pharma
  • Class DNA vaccines; Food allergy immunotherapies
  • Mechanism of Action Th1 cell stimulants
  • Orphan Drug Status

    Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.

  • New Molecular Entity No

Highest Development Phases

  • Phase I Peanut hypersensitivity

Most Recent Events

  • 20 Dec 2016 ASP 0892 receives Fast Track designation for Peanut hypersensitivity [Intradermal] [IM] in USA
  • 22 Nov 2016 Immunomic Therapeutics has patent protection for LAMP-Vax™ technology in USA
  • 01 Oct 2016 Phase-I clinical trials in Peanut hypersensitivity (Prevention) in USA (IM) (NCT02851277)
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at so we can help.

Back to top